Insulin is a peptide hormone made by pancreatic beta cells in response to rising glucose and other nutrients. Its core job is to promote glucose uptake, suppress hepatic glucose output, and coordinate whether the body stores or burns fuel.

In longevity terms, fasting insulin is often more revealing than fasting glucose because it shows how hard the pancreas must work to maintain a normal glucose number. High insulin can precede prediabetes by years, making it a useful marker of early metabolic strain.

• Standard normal range: Many Swedish laboratories use a fasting reference interval of roughly 20-180 pmol/L, although assays vary and the local lab range should always be checked.

• Loovi optimal range: About 20-50 pmol/L fasting in an insulin-sensitive adult, assuming glucose is also stable and the sample was truly fasting.

• Aggressive risk-tier: Roughly 15-30 pmol/L fasting in a high-risk person, provided the result is not being distorted by under-fuelling, recent exercise, or assay variation.

Risk begins to rise when insulin is high-normal rather than just frankly elevated. A value that looks acceptable in isolation can still signal compensatory hyperinsulinaemia if glucose, triglycerides, waist circumference, or HOMA-IR are also drifting the wrong way.

• Finds early compensation: Insulin usually rises before glucose, so it can expose the stage where the pancreas is still holding the line but metabolic strain is already present.

• Quantifies insulin resistance: When fasting insulin is high, the body is typically requiring more hormone to do the same work, which is the core biology behind metabolic syndrome.

• Improves diabetes prevention logic: Tracking insulin together with glucose and HbA1c helps distinguish early resistance from later beta-cell failure.

• Connects to broader risk: Hyperinsulinaemia tends to cluster with visceral adiposity, high triglycerides, fatty liver, and a more atherogenic lipid profile.

• Insulin resistance: The most common reason for high fasting insulin is that tissues are not responding properly, so the pancreas compensates by secreting more.

• Central adiposity and fatty liver: Visceral fat and liver fat both worsen hepatic insulin clearance and resistance, which pushes fasting insulin upward.

• Diet, sleep, and stress: Repeated glycaemic load, poor sleep, and stress physiology all increase the insulin requirement needed to keep glucose normal.

• Beta-cell dysfunction: In later metabolic disease, insulin can fall because the pancreas can no longer keep up, so a low insulin is not always a sign of good health.

• Medication and timing effects: Exogenous insulin, some endocrine drugs, and a non-fasting draw can distort interpretation, which is why sample conditions matter.

• Improve insulin sensitivity: When muscles, liver, and adipose tissue respond better to insulin, the pancreas does not need to secrete as much to keep glucose in range.

• Reduce ectopic fat: Lower liver fat and visceral fat improve hepatic insulin clearance and reduce the compensatory hyperinsulinaemia that often accompanies metabolic syndrome.

• Use pharmacology when indicated: Metformin, GLP-1 receptor agonists, and weight-loss therapies can lower insulin demand by improving glucose handling and body composition.

• Protect beta-cell function: Better sleep, exercise, and lower chronic glycaemic load reduce the long-term stress that can exhaust pancreatic beta cells.

The number only makes sense when the whole metabolic context is known. Genetics, body composition, fasting status, and the rest of the glycaemic profile determine whether a high insulin is a compensation signal, an early warning, or part of a more established metabolic disorder.

Insulin is most useful when paired with glucose, HbA1c, and HOMA-IR. Triglycerides and ALT help show whether liver fat is part of the mechanism, while ApoB gives a better read on the vascular risk that often travels with insulin resistance.

Loovi is designed for exactly that kind of interpretation. The membership combines 120+ biomarkers, 1-on-1 consultations with longevity doctors, physical testing such as strength, mobility, and VO2 max, drop-in blood tests at 80+ clinics across Sweden, results in 3 days, unlimited chat, an evolving health plan, and Friskvardsbidrag-approved access from 295 SEK/month.

• What does it mean if my insulin is high but glucose is normal?

  That usually means the pancreas is compensating successfully for insulin resistance. The glucose number looks fine because the insulin signal is still strong enough to hold it there.

• Can exercise lower insulin?

  Yes. Muscle contraction improves glucose uptake and insulin sensitivity, so regular training reduces the amount of insulin needed to manage the same glucose load.

• Should I test insulin or HOMA-IR?

  They are closely related, but they are not identical. Insulin is the raw hormone measure, while HOMA-IR integrates insulin with fasting glucose to estimate insulin resistance.

• Is insulin available through Swedish primary care?

  Sometimes, but it is less routine than glucose or HbA1c. In practice, insulin is much more commonly used in preventive or specialist contexts than in a basic primary-care workup.

• How fast can insulin change?

  Quite fast, because it responds to recent food intake, sleep, stress, and activity. The biology can shift in days, even when the broader metabolic pattern takes longer to change.

• Do I need to fast before an insulin test?

  Yes, if you want a fasting insulin value that can be interpreted against a reference range. Recent meals will raise insulin and make the result much less useful for metabolic assessment.